Tag Archives: Clinical trial

Upcoming Webcast: The Visibility Solution

By George Koroneos | Published: March 15, 2010
The Visibility Solution: Delivering an Accurate View of Clinical Operations Thursday, April 1, 2010 at 11:00 AM PT; 2:00 PM ET; 16:00 GMT This event focuses on our Clinical Trials solution with HighPoint Solutions and is designed to illustrate how pharma companies can reduce the risk and expense of the clinical trial process with better use of [...]
Posted in Webcast | Also tagged , , , , , , | Leave a comment

JP Morgan Healthcare Conference Marked by Hesitant Optimism

By Pharm Exec | Published: January 13, 2010
Guest blog by Audrey S. Erbes, Principal, Erbes & Associates While last year’s meeting was dominated by the global economic crisis and its impact on the healthcare industry, this year’s presenters tried to give investors a glimmer of hope for better outcomes in the future. The fear that darkened moods of attendees in 2009 was gone [...]
Posted in Events, Guest Blog | Also tagged , , , , , | Leave a comment

The Case for Specialty Medicines: Is Industry Credible, or Culpable?

By William Looney | Published: November 11, 2009
What’s so special about specialty? This was the question lurking below the surface in many of the presentations at a conference hosted by Pharm Exec’s sister organization, CBI, in Philadelphia last week. Now that the blockbuster era is fading under a wave of patent expirations, big pharma is pinning its hopes on the specialty category [...]
Posted in Strategy | Also tagged , , , , , , | Leave a comment

A Lead Drug on the Way? All Eyes on FDA

By Brittany Agro | Published: November 4, 2009
For NeurogesX, a small biopharma company based in San Mateo, CA, time does not stand still. Every day preceding November 16 brings its flagship drug, Qutenza, one step closer to approval. Until then, the company has turned its energies to finalizing its US commercialization strategy. (NeurogesX previously entered into a commercialization agreement with Astellas Pharma [...]
Posted in Strategy | Also tagged , , , | Leave a comment

Pharma Celebrates its Own

By Andrew Sheivachman | Published: October 7, 2009
At the gala ceremony for the 2009 Prix Galien USA award on October 1, a paradigm shift in drug development took center stage. “The most successful new [cancer] therapies will be based on a precise molecular understanding of disease basis—that’s exactly what we did with Gleevec,” said keynote speaker Brian Druker, director of the Oregon Health [...]
Posted in Events | Also tagged , , , , , , , , , , , , | Leave a comment